Larimar Therapeutics price target raised to $12 from $11 at Wedbush [Yahoo! Finance]
Larimar Therapeutics, Inc. (LRMR)
Company Research
Source: Yahoo! Finance
The firm notes that last week, the company completed an upsized $100M offering following receipt of Breakthrough Therapy designation for nomlabofusp in Friedreich's ataxia. After incorporating the raise, Wedbush is also increasing its Q4 spending to tie with year-end 2025 cash $137M. While the firm acknowledges recent FDA decisions have been a source of concern for investors, Wedbush is encouraged Larimar continues to hold an active dialog with the agency. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now See Insiders' Hot Stocks on TipRanks Read More on LRMR: Disclaimer & Disclosure Report an Issue Larimar Therapeutics Announces Upsized Public Equity Offering Larimar Therapeutics 20M share S
Show less
Read more
Impact Snapshot
Event Time:
LRMR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LRMR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LRMR alerts
High impacting Larimar Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
LRMR
News
- Wedbush Raises its Price Target on Larimar Therapeutics (LRMR) to $13 [Yahoo! Finance]Yahoo! Finance
- Larimar Therapeutics (LRMR) was upgraded by Truist Financial Corporation to "strong-buy".MarketBeat
- Larimar Therapeutics (LRMR) had its price target raised by Wedbush from $12.00 to $13.00. They now have an "outperform" rating on the stock.MarketBeat
- Larimar Therapeutics GAAP EPS of -$0.73 misses by $0.22 [Seeking Alpha]Seeking Alpha
- Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire
LRMR
Earnings
- 3/19/26 - Miss
LRMR
Sec Filings
- 4/10/26 - Form PRE
- 3/19/26 - Form S-8
- 3/19/26 - Form 10-K
- LRMR's page on the SEC website